Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Neoadjuvant Therapy × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4 Plasma cell 1

Conditions

Multiple Myeloma 6 Recurrence 1 Neoplasms, Plasma Cell 1

Interventions

Dexamethasone 83 Cyclophosphamide 45 pomalidomide 39 Bortezomib 29 Lenalidomide 27 fludarabine phosphate 24 carfilzomib 22 Peripheral Blood Stem Cell Transplantation 20 Mycophenolic Acid 20 Calcium Dobesilate 20 daratumumab 18 Cyclosporine 18 Busulfan 16 Whole-Body Irradiation 15 Tacrolimus 15 Antilymphocyte Serum 15 Radiotherapy 14 Melphalan 14 Filgrastim 14 Methotrexate 11 fludarabine 10 Methylprednisolone 10 selinexor 9 elotuzumab 9 Cord Blood Stem Cell Transplantation 9 Etoposide 7 ixazomib 6 Thalidomide 6 Prednisone 6 Panobinostat 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02572492 2018-08-17

CARFI

Aalborg University Hospital

Phase 2 Unknown

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡